Bioasis Technologies (OTCMKTS:BIOAF) Shares Down 12.5%

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating)’s stock price fell 12.5% during trading on Tuesday . The stock traded as low as $0.14 and last traded at $0.14. 101,000 shares traded hands during trading, an increase of 424% from the average session volume of 19,291 shares. The stock had previously closed at $0.16.

The stock has a market cap of $10.14 million, a P/E ratio of -2.78 and a beta of 0.18. The company has a fifty day moving average of $0.18 and a 200 day moving average of $0.20.

Bioasis Technologies Company Profile (OTCMKTS:BIOAF)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases.

Featured Articles

• Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
• Should Silver Stocks Be A Part Of Your Portfolio?
• ABM Industries, A Clean Play For Dirty Economic Times 
• This Still Isn’t A Buyable Bottom For Stocks 
• Dividend-Paying Midstream Oil Companies That Could Help You The Mitigate Market Volatility
• Don’t Get Too Bullish On Lennar Even Though It’s A Good Buy 

Want More Great Investing Ideas?